0.00Open0.01Pre Close0 Volume91 Open Interest60.00Strike Price0.00Turnover4186.81%IV25.39%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0040Delta0.0015Gamma8041.00Leverage Ratio-19.1441Theta0.0000Rho-32.38Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet